Celecoxib nanocrystal-loaded dissolving microneedles with highly efficient for osteoarthritis treatment
Osteoarthritis (OA) is a prevalent degenerative disease that has a significant impact on patients’ lives. Celecoxib (CXB) is now primarily used to treat OA with oral dosing. CXB’s limited water solubility, on the other hand, restricts its therapeutic application. We developed a delivery system of dissolving microneedles (DMNs) loaded with CXB-nanocrystals (CXB-NCs) for the treatment of OA. Oral administration’s inefficiency and injectable administration’s poor compliance might be solved using DMNs. Furthermore, carrier-free NCs may dramatically increase the dissolution of drugs with poorly water-solubility, as well as the drug load of DMNs. Antisolvent precipitation was used to make CXB-NCs. CXB-NC@DMNs were prepared by mixing CXB-NCs with hyaluronic acid (HA) that had high mechanical qualities and could permeate the skin efficiently in vitro. The therapeutic effect of oral CXB-NCs was substantially better than that of the same dose of oral CXB in an in vivo pharmacodynamic trial, demonstrating that the preparation of CXB into NCs might greatly increase CXB bioavailability. Furthermore, we discovered that DMNs loaded with low-dose CXB-NCs had similar or even better efficacy than the oral CXB-NCs group. The findings suggested that CXB-NC@DMNs may be a very efficient and promising drug delivery strategy in the treatment of OA.
Qiuyue Wang, Xuejing Yang, Xun Gu, Fang Wei, Wenyu Cao, Lijie Zheng, Yingying Li, Tao Ma, Chuanbin Wu, Qingqing Wang, Celecoxib nanocrystal-loaded dissolving microneedles with highly efficient for osteoarthritis treatment, International Journal of Pharmaceutics, Volume 625, 2022, 122108, ISSN 0378-5173,
https://doi.org/10.1016/j.ijpharm.2022.122108.